date,title,source
Oct-17-18,"Can Allergan's Key Drugs, Solid Pipeline Abate Generic Woes?",Zacks
Oct-17-18,Allergan plans to file for U.S. approval of new migraine drug by Q1 of 2019,MarketWatch
Oct-17-18,Allergan Announces Completion of Two Positive Safety Studies for Ubrogepant - an Oral CGRP Receptor Antagonist for the Acute Treatment of Migraine,PR Newswire
Oct-17-18,5 Blue Chip Drug Stocks Poised for Long-Term Gains,Investopedia
Oct-19-18,"Ironwood Rides on Linzess' Progress, Stalls Lenisurad Drugs",Zacks
Oct-19-18,Allergan to Showcase Continued Eye Care Innovation with New Data on Investigational Medicines at the American Academy of Ophthalmology Annual Meeting,PR Newswire
